CASE REPORT
Year : 2017 | Volume
: 32 | Issue : 3 | Page : 227--229
An infrequent case of adult alveolar rhabdomyosarcoma with pancreatic metastases detected in F-18 FDG PET/CT
Aravintho Natarajan, Ameya Puranik, Nilendu Purandare, Archi Agrawal, Sneha Shah, Venkatesh Rangarajan
Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India
Correspondence Address:
Venkatesh Rangarajan
Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai - 400 012, Maharashtra
India
Abstract
Rhabdomyosarcoma (RMS) is a rare cancer in adults, comprising about 1% of all forms of adult cancer. Common sites of metastases are lungs, skeletal system, lymph nodes, and brain. Metastases of RMS to pancreas are infrequent. We report a case of adult orbital alveolar RMS with pancreatic metastases detected in F-18-fluorodeoxyglucose-positron emission tomography/computed tomography.
How to cite this article:
Natarajan A, Puranik A, Purandare N, Agrawal A, Shah S, Rangarajan V. An infrequent case of adult alveolar rhabdomyosarcoma with pancreatic metastases detected in F-18 FDG PET/CT.Indian J Nucl Med 2017;32:227-229
|
How to cite this URL:
Natarajan A, Puranik A, Purandare N, Agrawal A, Shah S, Rangarajan V. An infrequent case of adult alveolar rhabdomyosarcoma with pancreatic metastases detected in F-18 FDG PET/CT. Indian J Nucl Med [serial online] 2017 [cited 2023 Mar 26 ];32:227-229
Available from: https://www.ijnm.in/text.asp?2017/32/3/227/207884 |
Full Text
Introduction
Rhabdomyosarcoma (RMS) is a rare cancerous tumor in adults. RMS is an aggressive tumor and have a tendency to metastasize frequently. Common sites of metastases are lungs, skeletal system, lymph nodes and brain. Positron-emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) is useful for detection, staging, and monitoring a variety of tumors in adults. We report a case of adult orbital alveolar RMS with pancreatic metastases detected in F-18 FDG PET/CT and review the relevant literature available.
Case Report
A 35-year-old male presented with right orbital swelling and diminution of vision for the past 1 month. Biopsy of the orbital mass [Figure 1] revealed small round malignant cell arranged in nests, surrounded by fibrovascular stroma. On immunohistochemical evaluation, the tumor cells were positive for desmin and myogenin. The histopathological features were consistent with alveolar variant of rhabdomyosarcoma (alveolar rhabdomyosarcoma [ARMS]).[1] Subsequently, whole-body F-18-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scan was performed 60 min after intravenous injection of 300 MBq of 18 F-FDG, to assess the extent of disease. Maximum intensity projection image of the F-18-FDG-PET/CT scan [Figure 2] shows abnormal increased tracer uptake in the region of the right orbit, bilateral cervical region, mid-abdomen (arrow), and mid-lumbar region (block arrow). Fusion images reveal that the uptakes correspond to recurrent primary tumor [Figure 2], cervical nodes, pancreatic deposit [Figure 3], and marrow of L4 vertebrae and right pelvic bone. Considering the aggressive presentation of rhabdomyosarcoma (RMS), these features were suggestive of extensive metastases. It is noteworthy that the pancreatic lesion is inconspicuous in contrast-enhanced CT.{Figure 1}{Figure 2}{Figure 3}
Discussion
Soft tissue sarcomas (STSs) are rare cancers, comprising about 1% of all forms of cancer in the adult population.[2] RMS is an STS thought to arise from myogenic precursor cells of various anatomical sites. Although RMS is infrequent in adult, it is the most common STS in childhood and adolescence.[2] The histological subgroups of RMS are ARMS, embryonal RMS, pleomorphic RMS, RMS not otherwise specified with latter, and pleomorphic being frequent in adult patients.[3] While head and neck is the common site of primary in children, extremity tumors are common in adults.[4] Adult patients have generally poor prognosis compared to children.[5] Other important prognostic factors include size of tumor, presence of metastases, histological subtypes, and molecular characteristics. With multimodality treatment, the overall survival of nonmetastatic disease has improved to 45%.[6] Patients with metastatic disease have poorer prognoses and should be considered for novel treatment strategies, thus accurate staging is imperative.
Conventional investigations used for staging and restaging include cross-sectional imaging of the tumor, chest, abdomen, and pelvis; radiolabelled bone scan and bone marrow biopsy. A systematic review by Norman et al. concluded that FDG-PET/CT performed consistently better than conventional imaging in initial staging and restaging and has a potential role in assessing treatment response.[7]
Common sites of metastases reported by conventional investigations are lungs, skeletal system, lymph nodes, and brain, with hematogenous being common route of metastases.[8] However, anecdotal evidence of unusual metastases such as the breast, testes, subcutaneous tissue, and pancreas are not infrequent.[9] An autopsy report of 57 children who died from ARMS had reported the prevalence of pancreatic metastases in 67% of patients.[10] Jha et al. in a retrospective analysis reported the high prevalence of 11.2% for pancreatic metastases in ARMS.[11]
While increased blood supply to the developing breast has been attributed to breast metastases in adolescents, cause of pancreatic metastases is poorly understood. Influence of chromosomal translocation (PAX3/7-FKHR fusion gene, characteristic for ARMS) over insulin-like growth receptors of the pancreas has been hypothesized for the cause of pancreatic metastases.[11]
Conclusion
FDG-PET/CT has superior diagnostic accuracy over conventional imaging for the evaluation of distant metastases of RMS. Pancreatic metastases of RMS though infrequent are not as rare as initially thought to be especially in alveolar variant.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
| 1 | Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14. |
| 2 | Morrison BA. Soft tissue sarcomas of the extremities. Proc Bayl Univ Med Cent 2003;16:285-90. |
| 3 | Duan F, Smith LM, Gustafson DM, Zhang C, Dunlevy MJ, Gastier-Foster JM, et al. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: A report from the Children's Oncology Group. Genes Chromosomes Cancer 2012;51:662-74. |
| 4 | Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol 2009;27:3391-7. |
| 5 | Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O'Leary M, et al. Outcomes for children and adolescents with cancer: Challenges for the twenty- first century. J Clin Oncol 2010;28:2625-34. |
| 6 | Gerber NK, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, et al. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. Int J Radiat Oncol Biol Phys 2013;86:58-63. |
| 7 | Norman G, Fayter D, Lewis-Light K, Chisholm J, McHugh K, Levine D, et al. An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: Systematic review. BMJ Open 2015;5:e006030. |
| 8 | Dagher R, Helman L. Rhabdomyosarcoma: An overview. Oncologist 1999;4:34-44. |
| 9 | Khalbuss WE, Gherson J, Zaman M. Pancreatic metastasis of cardiac rhabdomyosarcoma diagnosed by fine needle aspiration. A case report. Acta Cytol 1999;43:447-51. |
| 10 | Enzinger FM, Shiraki M. Alveolar rhabdomyosarcoma. An analysis of 110 cases. Cancer 1969;24:18-31. |
| 11 | Jha P, Frölich AM, McCarville B, Navarro OM, Babyn P, Goldsby R, et al. Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: Emerging role of PET-CT in tumor staging. Pediatr Radiol 2010;40:1380-6. |
|
